Abstract: A casing of an electronic device and a manufacturing method thereof are provided. The casing comprises a metal shell, a painting layer and a micro-arc oxidation (MAO) layer. The MAO layer is formed between the metal shell and the painting layer.

Abstract: A spring mattress structure comprises a mattress body with a top bed surface and a bottom bed surface which consists of a plurality of shaft levers separated by a regular spacing between any two adjacent shaft levers and prepared for placement of a plurality of springs; each of the springs allows the bottom's both ends to be placed on surfaces of two adjacent shaft levers and develops a hollow space which correspond to a spacing developed by the two adjacent shaft levers; the bottom of each spring is fixed on one of the shaft levers with a spring-loaded locating piece so that the spring is securely connected to the shaft lever.

Abstract: A manufacturing method of a casing of an electronic device including the following steps is provided. First, a casing body is formed by an injection molding technology, and the casing body includes a button portion. Thereafter, a sensing assembly is electroplated on an inner surface of the casing body. The sensing assembly includes a first conductive line and two first contacts. The first conductive line forms a strain sensing pattern on the button portion, and the two first contacts connect to two ends of the first conductive line, respectively.

Abstract: Pharmaceutical composition comprising antibodies or antigen binding fragments thereof that bind to globo H, SSEA3, and SSEA-4 are disclosed herein, as well as methods of use thereof. Methods of use include, without limitation, cancer therapies and diagnostics. The antibodies of the disclosure can bind to certain cancer cell surfaces. Exemplary targets of the antibodies disclosed herein can include carcinomas, such as those in brain, skin, bone, lungs, breast, esophagus, stomach, liver, bile duct, pancreas, colon, kidney, cervical, ovarian, and/or prostate cancer.

Abstract: The present disclosure provides a semiconductor device. The semiconductor device includes a first doped region and a second doped region both formed in a substrate. The first and second doped regions are oppositely doped. The semiconductor device includes a first gate formed over the substrate. The first gate overlies a portion of the first doped region and a portion of the second doped region. The semiconductor device includes a second gate formed over the substrate. The second gate overlies a different portion of the second doped region. The semiconductor device includes a first voltage source that provides a first voltage to the second gate. The semiconductor device includes a second voltage source that provides a second voltage to the second doped region. The first and second voltages are different from each other.

Abstract: A MitoCells treated with angelica extract is provided. The pharmaceutical composition comprise MitoCells and can significantly achieve the goal for treating degenerative neurological disease.

Abstract: A set-top box device capable of providing electrical power to an antenna includes an insulation housing, a printed circuit board, a metal portion, and a conductive locking member. The insulation housing has at least one lateral arranged thereon a through hole portion. The printed circuit board is arranged in the insulation housing and includes a power supply module. The metal portion is arranged on the printed circuit board and includes a locking hole corresponding the through hole portion. The conductive locking member passes through the locking hole, the through hole portion, a conductive end portion of the power supply line, and the metal portion. The power supply module feeds a current into the antenna through a connection of the metal portion, the conductive locking member, and the conductive end portion, and the current flows to a ground portion of the signal line thereby forming a power supply loop.

Abstract: The invention provides an antibody specific to the ANGPTL4 protein capable of neutralizing proliferation and methods of making and using the same. The antibody of the invention is further directed to the C terminal region of the protein and may be capable of neutralizing cell proliferation and treating cancer. The antibody may be monoclonal and/or humanized antibody.

Abstract: In an embodiment of the disclosure, a separator utilized in a lithium battery is provided. The separator includes a non-woven polyester support, a porous layer of polyvinylidene fluoride (PVDF) or its derivatives formed on the non-woven polyester support, a layer of UV-curing or thermal-curing polymers formed on top of the porous layer of polyvinylidene fluoride (PVDF) or its derivatives.

Abstract: A method for semiconductor devices on a substrate includes using gate structures which serve as active gate structures in a MOSFET region, as dummy gate structures in a JFET region of the device. The dummy gate electrodes are used as masks and determine the spacing between gate regions and source/drain regions, the width of the gate regions, and the spacing between adjacent gate regions according to some embodiments, thereby forming an accurately dimensioned transistor channel.

Abstract: A system for monitoring a plurality radio frequency identification tags is described. The system uses at least one set of radio frequency identification tags. Each tag is attached to a container and includes several sensors for detecting physical conditions of said container. The system includes at least one autonomous intermediate reader in wireless communication with the frequency identification tags. The intermediate reader includes external wireless communication system, intermediate reader logic controller, and a self-contained rechargeable power supply. The system uses a central status reporting system in communication the intermediate reader.

Abstract: A LED package structure includes a substrate unit, a light-emitting unit and a package unit. The substrate unit includes two lead frames, and light-emitting unit including a LED chip electrically connected between the two lead frames. The package unit includes a light-transmitting package body enclosing the light-emitting unit and one part of each lead frame and a lens body integrated with the light-transmitting package body, and another part of each lead frame is exposed from the light-transmitting package body. Therefore, light beams generated by the LED chip pass through the lens body to project a cross light pattern on a plane, the cross light pattern has a concentrated cross light shape and a scattered light shape surrounding the concentrated cross light shape, the luminous intensity of the concentrated cross light shape is substantially the same and larger than the luminous intensity of the scattered light shape.

Abstract: The present disclosure provides antibodies that bind to human interleukin-6 (IL6). The antibodies can modulate IL6 signaling and thus used in treatment or prevention of IL6 associated diseases or disorders, particularly inflammatory disorder, rheumatoid arthritis (RA), angiogenesis, and cancer.

Abstract: The invention relates to the C-terminal fragment of angiopoietin-related protein 4 [cAngptl4] as a diagnostic marker for viral and bacterial pneumonia; anti-angiopoietin-related protein 4 therapeutic antibodies, and the use of anti-angiopoietin-related protein 4 antibodies in the treatment of viral and bacterial pneumonia.

Abstract: The present disclosure provides a semiconductor device. The semiconductor device includes a first doped region and a second doped region both formed in a substrate. The first and second doped regions are oppositely doped. The semiconductor device includes a first gate formed over the substrate. The first gate overlies a portion of the first doped region and a portion of the second doped region. The semiconductor device includes a second gate formed over the substrate. The second gate overlies a different portion of the second doped region. The semiconductor device includes a first voltage source that provides a first voltage to the second gate. The semiconductor device includes a second voltage source that provides a second voltage to the second doped region. The first and second voltages are different from each other.

Abstract: Pharmaceutical composition comprising antibodies or antigen binding fragments thereof that bind to SSEA-4 are disclosed herein, as well as methods of use thereof. Methods of use include, without limitation, cancer therapies and diagnostics. The antibodies of the disclosure can bind to certain cancer cell surfaces. Exemplary targets of the antibodies disclosed herein can include carcinomas, such as those in brain, lung, breast, mouse, esophagus, stomach, liver, bile duct, pancreas, colon, kidney, cervix, ovary, and/or prostate cancer.

Abstract: A coaxial cable connector configured to be mounted to an externally threaded connector, comprising a nut portion having an inner thread configured to engage with an outer thread of said externally threaded connector, an inner-sleeve portion coaxially arranged with said nut and a first sleeve coaxially arranged with said nut, wherein said first sleeve comprises an inner flange radially on an outer wall of said inner-sleeve portion, characterized in that: when said nut is rotated relatively to said first sleeve, said inner-sleeve portion is rotated relatively to said first sleeve.

Abstract: A method for simultaneously forming JFET devices and MOSFET devices on a substrate includes using gate structures which serve as active gate structures in the MOSFET region, as dummy gate structures in the JFET portion of the device. The dummy gate electrodes are used as masks and determine the spacing between gate regions and source/drain regions, the width of the gate regions, and the spacing between adjacent gate regions according to some embodiments. The transistor channel is therefore accurately dimensioned.

Abstract: An isolated monoclonal antibody or an antigen-binding fragment thereof is disclosed. The antibody or the antigen-binding fragment is characterized by: (a) having a specific binding affinity to epithelial cell adhesion molecule (EpCAM) comprising the amino acid sequence of SEQ ID NO: 1; (b) having a specific binding affinity to cancer cells expressing EpCAM said cancer cells being selected from the group consisting of oral cancer cells, nasopharyngeal cancer cells (NPC), colorectal cancer cells, and ovarian cancer cells; and (c) having no binding affinity to human umbilical vein endothelial cell (HUVEC) and normal nasal mucosal epithelia (NNM). Also disclosed is an isolated monoclonal antibody or an antigen-binding fragment thereof that has a specific binding affinity to an epitope within the sequence of KPEGALQNNDGLYDPDCDE (SEQ ID NO: 63) located within the EGF-like domain II of epithelial cell adhesion molecule (EpCAM). Methods of using the same are also disclosed.

Abstract: A semiconductor device is provided and includes a substrate of a first conductivity type, a deep well of a second conductivity type, and a first high-side device. The deep well is formed on the substrate. The first high-side device is disposed within the deep well and includes an insulation layer of the second conductivity type, a well of the first conductivity type, first and second regions of the second conductivity type, and a first poly-silicon material. The insulation layer is formed on the substrate. The well is formed within the deep well. The first and second regions are formed within the well. The first poly-silicon material is disposed between the first region and the second region and on the deep well.